Successful Treatment of an Immune-Mediated Colitis Induced by Checkpoint Inhibitor Therapy in a Patient with Advanced Melanoma

Successful Treatment of an Immune-Mediated Colitis Induced by Checkpoint Inhibitor Therapy in a Patient with Advanced Melanoma

Immune checkpoint inhibitors (ICIs) have been used as immunotherapeutic agents in several malignancies because of their ability to modify the T cell-mediated response against tumor cells. Dual checkpoint inhibition improves remission rates in patients with metastatic melanoma compared to monotherapy...

Full description

Bibliographic Details
Main Authors: Maria Paparoupa, Sophie Stupperich, Lisa Goerg-Reifenberg, Andreas Wittig, Frank Schuppert
Format: Article
Language:English
Published: Karger Publishers 2020-10-01
Series:Case Reports in Gastroenterology
Subjects:
immune checkpoint inhibitor
nivolumab
ipilimumab
infliximab
immune-related adverse events
Online Access:https://www.karger.com/Article/FullText/511252

Similar Items

Similar Items